Objective
The aim of ROADMAP is to provide the foundation for a Europe-wide real world evidence (RWE) platform in AD by piloting multi-modal data integration tools and engaging with all key stakeholder groups for consensual definition of patient outcomes, tools and methods that are actionable and relevant. ROADMAP will leverage best practice and exploit synergies with other projects and initiatives at the national and European levels in pursue of scalable and transferable solutions for dataset characterisation, outcome classification, data standards, data sourcing, software application and guidelines on the handling and interpretation of RWE data. In parallel, the project will deepen understanding of the ethical, legal and social implications (ELSI) and health economics (HE) impact of a RWE approach for a meaningful contribution to the Big Data for Better Outcomes programme in IMI2.
The ROADMAP programme will consist of 8 integrated work packages by which the Consortium will work to (1) identify relevant AD outcomes and progression markers; (2) identify and pool AD-related RWE across data sources; (3) develop and validate disease progression models combining diverse datasets and strategies; (4) develop risk/value-based costing and health economics models for HTA/regulators, service providers, industry and carers; (5) establish stakeholder-based guidelines for RWE; (6) develop a communication strategy focussing on the needs of patients and professionals; (7) develop an ELSI framework for the development and application of RWE in AD.
The ROADMAP consortium brings together outstanding expertise, experience and traction in the field, including many of Europe’s top institutions, authorities, companies, experts in AD, biomedical informatics and analysis of epidemiologic and routinely collected health data sources, providing direct connections to key initiatives such as DPUK, EMIF, EPAD and others.
Fields of science
- medical and health sciencesbasic medicineneurologydementiaalzheimer
- medical and health sciencesbasic medicinepathology
- medical and health scienceshealth sciencespersonalized medicine
- social scienceseconomics and businesseconomicshealth economics
- natural sciencescomputer and information sciencessoftwaresoftware applications
Programme(s)
Funding Scheme
RIA - Research and Innovation actionCoordinator
OX1 2JD Oxford
United Kingdom
See on map
Participants (25)
M1 4BT Manchester
See on map
3015 GD Rotterdam
See on map
6200 MD Maastricht
See on map
28006 Madrid
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
08007 Barcelona
See on map
1165 Kobenhavn
See on map
1736 SENNINGERBERG
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
EH8 9YL Edinburgh
See on map
405 30 Goeteborg
See on map
8000 Aarhus C
See on map
WC2A 2AE London
See on map
3531AH Utrecht
See on map
EC1A 9PN London
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
9712CP Groningen
See on map
4056 Basel
See on map
RG21 4FA Basingstoke
See on map
SL6 3AY Maidenhead
See on map
4070 Basel
See on map
2340 Beerse
See on map
HP8 4SP CHALFONT ST GILES
See on map
1015 Lausanne
See on map
WC2B 4AE London
See on map
2500 Valby
See on map
2333 ZA Leiden
See on map
33404 Talence
See on map